Skip to main content
. 2014 Jan 2;2014(1):CD006569. doi: 10.1002/14651858.CD006569.pub5

1. Titles for reviews suggested by excluded studies.

Suggested title/ongoing title Excluded study Reference to relevant ongoing Cochrane title*
Alpha‐receptor agonists for schizophrenia Bergman 2007   Currently no review.
Antidepressant augmentation of antipsychotic drugs for schizophrenia Fawzi 2009   Whitehead 2002
Aripiprazole augmentation of other antipsychotics for schizophrenia Bristol‐Myers 2006, Shim 2006 Maayan 2011
Aripiprazole for people with metabolic syndrome Colombo 2008 Mukundan 2010
Aripiprazole versus first generation antipsychotics for schizophrenia Carson 2000, Mossner 2009, Talbott 2007, Taylor 2007 Bhattacharjee 2008
Aripiprazole versus placebo for schizophrenia Carson 2000, Henderson 2009, Mortimer 2004 Belgamwar 2011
Augmentation of clozapine for schizophrenia Fleischhacker 2008a, Kim 2006, Ma 2007, Millar 2008, Namey 2006, Remington 2009     Cipriani 2009
Psychosocial intervention for schizophrenia Anon 2008 Unclear which of the many reviews would be relevant.
Switching from other antipsychotics to aripiprazole for schizophrenia Janssen 2005, Lan 2008, Pae 2009a, Schreiner 2009, Takeuchi 2008   Mukundan 2010

* It is possible that these studies could also contribute to other titles not referenced in this column.